4.7 Review

Clinical and Molecular Features of Early Infantile Niemann Pick Type C Disease

Journal

Publisher

MDPI
DOI: 10.3390/ijms21145059

Keywords

Niemann Pick disease type C; early infantile onset; neurological manifestations

Funding

  1. Scientific and Technological Research Council of Turkey (TUBITAK)
  2. Medical Research Council Fellowship [MR/T008024/1]
  3. NIHR Great Ormond Street Hospital Biomedical Research Centre
  4. UK Medical Research Council [MR/N026101/1, MR/S036784/1, MR/R025134/1, MR/R015325/1, MR/S009434/1]
  5. Wellcome Trust Institutional Strategic Support Fund/UCL Therapeutic Acceleration Support (TAS) Fund [204841/Z/16/Z]
  6. Action Medical Research [GN2485]
  7. Asociacion Niemann Pick de Fuenlabrada
  8. MRC [MR/T008024/1] Funding Source: UKRI

Ask authors/readers for more resources

Niemann Pick disease type C (NPC) is a neurovisceral disorder due to mutations inNPC1orNPC2. This review focuses on poorly characterized clinical and molecular features of early infantile form of NPC (EIF) and identified 89 cases caused byNPC1(NPC1) and 16 byNPC2(NPC2) mutations. Extra-neuronal features were common; visceromegaly reported in 80/89 NPC1 and in 15/16 NPC2, prolonged jaundice in 30/89 NPC1 and 7/16 NPC2. Early lung involvement was present in 12/16 NPC2 cases. Median age of neurological onset was 12 (0-24) and 7.5 (0-24) months in NPC1 and NPC2 groups, respectively. Developmental delay and hypotonia were the commonest first detected neurological symptoms reported in 39/89 and 18/89 NPC1, and in 8/16 and 10/16 NPC2, respectively. Additional neurological symptoms included vertical supranuclear gaze palsy, dysarthria, cataplexy, dysphagia, seizures, dystonia, and spasticity. The following mutations in homozygous state conferred EIF: deletion of exon 1+promoter, c.3578_3591 + 9del, c.385delT, p.C63fsX75, IVS21-2delATGC, c. 2740T>A (p.C914S), c.3584G>T (p.G1195V), c.3478-6T>A, c.960_961dup (p.A321Gfs*16) inNPC1and c.434T>A (p.V145E), c.199T>C (p.S67P), c.133C>T (p.Q45X), c.141C>A (p.C47X) inNPC2. This comprehensive analysis of the EIF type of NPC will benefit clinical patient management, genetic counselling, and assist design of novel therapy trials.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available